These results underscore the potential therapeutic significance of HucMSC-Exo exosomes, underscoring the Nrf2/NQO-1 pathway’s role in alleviating oxidative stress and inflammation in NASH (Kang et al., 2022). The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatohepatitis.